| Issue |
Section |
Title |
File |
| Vol 96, No 2 (2020) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
The Actual Challenges of Biologics Treatment in Patients with Psoriasis |
(Rus)
|
| Vol 96, No 2 (2020) |
EDITORIAL |
Recommendations Russian Society of Dermatovenerologists and Cosmetologists
for systemic treatment of psoriasis during the pandemic COVID-19 |
(Rus)
|
| Vol 97, No 4 (2021) |
ORIGINAL STUDIES |
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial |
(Rus)
|
| Vol 97, No 4 (2021) |
REVIEWS |
Revisiting the question of cutaneous vasculitis classification |
(Rus)
|
| Vol 98, No 4 (2022) |
REVIEWS |
Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab |
(Rus)
|
| Vol 98, No 6 (2022) |
REVIEWS |
Revisiting the question of assessment by severity and classification of acne |
(Rus)
|
| Vol 98, No 6 (2022) |
GUIDELINES FOR PRACTITIONERS |
About the relationship of rosacea-like dermatitis |
(Rus)
|
| Vol 99, No 5 (2023) |
GUIDELINES FOR PRACTITIONERS |
Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice |
(Rus)
|
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).